Trimas Corp: Form 10-K for the period ended Dec 31, 2025
Filed with the SEC on Mar 2, 2026 and accepted by EDGAR at Mar 2, 2026, 14:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-10-01 to 2025-12-31 | $155.5m | us-gaap:Revenues |
| Revenue | 12 months2025-01-01 to 2025-12-31 | $645.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $507.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-10-01 to 2025-12-31 | $32.9m | us-gaap:GrossProfit |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $138.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2025-01-01 to 2025-12-31 | $129.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $41.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $18.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2025-01-01 to 2025-12-31 | −$48.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | $81.7m | us-gaap:NetIncomeLoss |
| Net income | 12 months2025-01-01 to 2025-12-31 | $120.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | $2.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $2.95 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | $2.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $2.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 40,148,066 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 40,790,137 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $117.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $48.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $6.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $103.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $30.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $462.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $1.49bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $183.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $779.5m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $472.8m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2025-12-31 | $705.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000842633-26-000012. Last ingested by Listed: Oct 29, 2026, 09:45 ET. Listed shows no prices and gives no investment advice.